Oisin Biotechnologies, Inc. — Form D
Oisin Biotechnologies, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-06. The offering totals $5.0M, of which $475K was reported sold. Industry: Other.
Offering
- Filed: 2021-08-06
- Form: D
- Accession: 0001801885-21-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $475K
- Remaining: $4.5M
- Investors: 8
- Date of first sale: 2021-07-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-409178
Issuer
- Name: Oisin Biotechnologies, Inc.
- CIK: 0001801885
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 800 5TH AVENUE, SUITE 4100, SEATTLE, WA, 98104
- Phone: 206-880-1166
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| John Lewis | Executive Officer | Gibsonia, PA |
| Eric Garcia | Executive Officer | Seattle, WA |
| Matthew Scholz | Director | Seattle, WA |
| Matthew Scholz | Executive Officer | Seattle, WA |
| David Gobel | Director | Seattle, WA |
| Stephen Hilbert | Executive Officer | Seattle, WA |
| Gary Hudson | Director | Seattle, WA |
| Gary Hudson | Executive Officer | Seattle, WA |
| Danjuma Quarless | Director | Seattle, WA |
| Steve Hilbert | Executive Officer | Seattle, WA |
Other filings by this issuer (4)
More